Robert T Galvin

Robert T Galvin serves as an Assistant Professor in Pediatric Hematology/Oncology at the University of Minnesota. His clinical and research focus centers on pediatric cancers, with emphasis on neurofibromatosis, childhood brain tumors, and genetic mechanisms driving malignancy.

Dr. Galvin's research spans Pediatric Oncology, Childhood Cancer, Neurofibromatosis, and Pediatric Low-grade Glioma. He investigates genetic alterations (e.g., MYO5A::FGFR1 fusions), central nervous system malignancies in cancer survivors, and immunomodulatory targets in pediatric CNS tumors. His work integrates molecular biology with therapeutic development, including MEK inhibitors and oncolytic viruses for malignant peripheral nerve sheath tumors.

His recent publications (2023-2025) demonstrate a cohesive focus on pediatric neuro-oncology. Key themes include genetic characterization of gliomas, epidemiology of secondary CNS malignancies in childhood cancer survivors, and novel therapeutic approaches. Notably, he employs computational pipelines for drug discovery in glioblastoma and explores pan-histology immunomodulatory targets across pediatric brain tumors.